Mankind Pharma Limited has informed the Exchange about Schedule of meet
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mankind Pharma has scheduled an earnings call for Wednesday, May 20, 2026 at 12:00 PM IST to discuss Q4 and FY26 business performance. The call will feature key senior management including Vice Chairman & MD Rajeev Juneja, CEO Sheetal Arora, COO Arjun Juneja, CFO Ashutosh Dhawan, and other senior executives. This is a routine investor relations activity filed under SEBI Regulations 30 & 51. No financial results or guidance are disclosed in this filing — actual Q4/FY26 numbers will be shared during the call. The company is listed on both BSE (code: 543904) and NSE (symbol: MANKIND).
This is a standard pre-result announcement filing. It signals that Q4 and FY26 results are imminent and gives investors an opportunity to engage with management. No direct stock price impact expected from this disclosure itself.